At 达仁 DaRen Biotech, our patented CAR-T immunotherapies kill 80% of cancers.
We leverage the existing immune system to fight cancer and other pathogens through our diversified pipeline of new generation Immunotherapy products.
24 hours of T-Cells With Liver Cancer Cells
Our DR CAR-T
DR CAR-T Cells
24 hours of DR CAR-T Cells With Liver Cancer Cells
Solid tumours create a protective barrier of T-reg cells to stop any CAR-T cells from being effective. DaRen has evidence that our DR CAR-T will wipe out the T-regs allowing the DR CAR-T to penetrate the tumour.
We target a variety of markers on the cancer surface with one CAR-T, making it nearly impossible for the cancer to escape via heterogeneity. This also allows DaRen to Target 80% of all cancers with one CAR-T.
Our CAR-T specifically targets cancer cells and does not target healthy cells.